MTD acquires Ypsomed's pen needle and BGM businesses

MTD (Medical Technology and Devices) announced the acquisition of Ypsomed's pen needle and blood glucose monitoring (BGM) businesses. The deal strengthens MTD's position in diabetes care and is expected to close in summer 2024.

“MTD announces the acquisition of Ypsomed's pen needle and blood glucose monitoring (BGM) businesses.”prnewswire.com

• 1 source
• prnewswire.comMTD acquires Ypsomed's pen needle and BGM businesses, strengthening its leading position in diabetes careMTD Medical Technology, Devices S.p.A.Mar 27, 2024

Summarized from public sources; check the original articles before acting on it.